Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1614 1618
This examiner grants 63% of resolved cases
Robert S. Cabral serves as an examiner within Tech Center 1600 and Art Unit 1614. The examiner has reached a final disposition in 866 resolved cases, maintaining an allowance rate of 62.6 percent. This percentage indicates the frequency with which applications are granted. The history of 866 cases provides a foundation for understanding the examiner's patterns in Art Unit 1614.
The data shows an interview lift of 32.5 percent. This metric reflects the difference in allowance probability when an interview occurs during the prosecution process. Additionally, the median days to allowance is 2033. This number represents the middle point of the time required for an application to move from its filing date to the issuance of a patent.
For those appearing before this examiner, the 62.6 percent allowance rate and the 32.5 percent interview lift are primary considerations for strategy. The 2033 median days to allowance offers a benchmark for the expected duration of the process. These figures summarize the current prosecution environment for Robert S. Cabral.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17998761 | CARBON NANOTUBES AND COMPLEXES THEREOF FOR TREATING AND DETECTING OCULAR TUMORS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18886294 | Near Infrared Fluorescent Dyes, Formulations and Related Methods | Non-Final OA | Washington University |
| 18014729 | ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDES TO SAID CELLS | Non-Final OA | Hoffmann-La Roche Inc. |
| 18272110 | CAVITATION AGENT | Final Rejection | Oxford University Innovation Limited |
| 18755082 | ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF | Non-Final OA | L.E.A.F. HOLDINGS GROUP LLC |
| 18908740 | ULTRASMALL NANOPARTICLES AND METHODS OF MAKING AND USING SAME | Non-Final OA | CORNELL UNIVERSITY |
| 18780262 | METHOD OF TREATMENT FOR SOLID TUMORS CONTAINING HYPOXIA AND/OR STROMA FEATURES | Non-Final OA | Wayne State University |
| 18913441 | Compositions of Hypochlorous Acid (HOCL) and Methods Of Manufacture Thereof | Non-Final OA | WIAB WATER INNOVATION AB |
| 18751742 | Formulated and/or Co-Formulated Liposome Compositions Containing PD-1 Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof | Non-Final OA | Nammi Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy